This organ protection measure in patients undergoing laparoscopic colorectal cancer resection decreased the incidence of postoperative gastrointestinal dysfunction and lowered the IL-6, TNF-α, and I-FABP levels, demonstrating protective effect on patients’ postoperative gastrointestinal function [40]. The gene discussed is FABP2; the disease is colorectal cancer.